Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases

• Published in: Journal of ophthalmic inflammation and infection Vol. 3; no. 1; p. 47
• Main Authors: Alio, Jorge L, Abbouda, Alessandro, Valle, David Diaz, del Castillo, Jose M Benitez, Fernandez, Jose A Gegundez
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 29.05.2013; Springer Nature B.V; Springer
• Subjects: Cornea; Eye diseases; Fungal infections; Infections; Medicine; Medicine & Public Health; Meta-analysis; Ophthalmology; Original Research; Infectious keratitis; UV-A; Corneal melting; Collagen cross linking
• ISSN: 1869-5760; 1869-5760
• DOI: 10.1186/1869-5760-3-47

Background Collagen cross linking (CXL) of the cornea has been developed recently as a new treatment for multidrug-resistant infectious keratitis. The aim of this study is to summarize the previously published data and evaluate the effectiveness of this treatment. Results The search identified 12 articles. The number of eyes was 104. The infectious keratitis was associated with bacteria in 58 eyes (57f%): Gram-positive bacteria in 44 (43%; 4 of which were infected with Mycobacterium (3.6%)) and Gram-negative bacteria in 14 eyes (13%), fungus in 13 eyes (12%), and Acanthamoeba in 7 eyes (7%). In 26 eyes (25%), the microbiological culture was negative or not performed. The mean time of re-epithelization after CXL was 20.7±28.1 days (minimum of 3, maximum of 145). Sixteen eyes underwent deep or lamellar keratoplasty. The pooled analysis suggested that CXL has a favorable effect on the block of corneal melting in 85% (95%; CI 0.77, 0.91) of eyes. Conclusion Although randomized controlled trials are needed, the available evidence supports the use of CXL in the treatment of infectious keratitis.